ATE519769T1 - BISPHOSPHONATE COMPOUNDS AND METHODS FOR BONE WASTING DISEASES, CANCER, BONE PAIN, IMMUNE DISORDERS AND INFECTIOUS DISEASES - Google Patents

BISPHOSPHONATE COMPOUNDS AND METHODS FOR BONE WASTING DISEASES, CANCER, BONE PAIN, IMMUNE DISORDERS AND INFECTIOUS DISEASES

Info

Publication number
ATE519769T1
ATE519769T1 AT05824408T AT05824408T ATE519769T1 AT E519769 T1 ATE519769 T1 AT E519769T1 AT 05824408 T AT05824408 T AT 05824408T AT 05824408 T AT05824408 T AT 05824408T AT E519769 T1 ATE519769 T1 AT E519769T1
Authority
AT
Austria
Prior art keywords
bone
diseases
cancer
methods
immune disorders
Prior art date
Application number
AT05824408T
Other languages
German (de)
Inventor
John M Sanders
Yongcheng Song
Julian M W Chan
Eric Oldfield
Yonghui Zhang
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Priority claimed from PCT/US2005/036425 external-priority patent/WO2006039721A2/en
Application granted granted Critical
Publication of ATE519769T1 publication Critical patent/ATE519769T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/60—Quinoline or hydrogenated quinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/62—Isoquinoline or hydrogenated isoquinoline ring systems
AT05824408T 2004-10-08 2005-10-07 BISPHOSPHONATE COMPOUNDS AND METHODS FOR BONE WASTING DISEASES, CANCER, BONE PAIN, IMMUNE DISORDERS AND INFECTIOUS DISEASES ATE519769T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61710804P 2004-10-08 2004-10-08
US42502505A 2005-10-07 2005-10-07
PCT/US2005/036425 WO2006039721A2 (en) 2004-10-08 2005-10-07 Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases

Publications (1)

Publication Number Publication Date
ATE519769T1 true ATE519769T1 (en) 2011-08-15

Family

ID=38116019

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05824408T ATE519769T1 (en) 2004-10-08 2005-10-07 BISPHOSPHONATE COMPOUNDS AND METHODS FOR BONE WASTING DISEASES, CANCER, BONE PAIN, IMMUNE DISORDERS AND INFECTIOUS DISEASES

Country Status (1)

Country Link
AT (1) ATE519769T1 (en)

Similar Documents

Publication Publication Date Title
EP1802641A4 (en) Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
ZA200702130B (en) Memantine for the treatment of childhood behavioral disorders
DK1817282T3 (en) Suitable phenoxy derivatives for the treatment of respiratory diseases
IL227745A0 (en) Methods for manufacturing dental implant components
EP1868521A4 (en) Response surfaces for orthodontic treatment planning
EP1883444A4 (en) Self-clearing catheter for clinical implantation
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
IL227841A0 (en) Dihydropteridinones for the treatment of cancer diseases
ZA200606049B (en) Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral disease
DK1833462T3 (en) PHARMACEUTICAL PREPARATION FOR HEAT STERILIZED GLUCOCORTICOID SUSPENSIONS
PT2422786E (en) New medicine combinations for treating respiratory diseases
NL1028599A1 (en) Compounds for the treatment of diseases.
DE502004011765D1 (en) Implant for spreading the nostrils
DK1786354T3 (en) Dental implant system
IL185444A0 (en) Novel drugs for treating respiratory diseases
HU0500145D0 (en) Composition for the treatment of oral diseases
ATE448228T1 (en) PYRROLOPYRIMIDE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES
GB0400802D0 (en) Compounds for the treatment of disease
ATE519769T1 (en) BISPHOSPHONATE COMPOUNDS AND METHODS FOR BONE WASTING DISEASES, CANCER, BONE PAIN, IMMUNE DISORDERS AND INFECTIOUS DISEASES
EP1866326A4 (en) Immunogens for vaccines against antigenically variable pathogens and diseases
ITMI20051207A1 (en) IMPLANT STRUCTURE FOR DENTAL PROSTHESIS
EP1927353A4 (en) Remedy for corneal diseases
ES1060498Y (en) DISPOSABLE DENTAL BASTONCILLO.
ITVI20050138A1 (en) POSITIONING DEVICE FOR THE MANUFACTURE OF DENTAL PROSTHESIS
GB0516753D0 (en) Molecular methods for the treatment of disease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties